Cognitive effects of hormone therapy in men with prostate cancer: A review Review uri icon

Overview

MeSH Major

  • Androgen Antagonists
  • Cognition
  • Neoplasms, Hormone-Dependent
  • Prostatic Neoplasms

abstract

  • There is a strong argument that androgen-ablation therapy is linked to subtle but significant cognitive declines in men with prostate cancer. The authors believe that clinicians should become aware of this correlation as the use of ADT increases and should inform and monitor patients for this possible side effect of treatment.

publication date

  • September 2008

Research

keywords

  • Review

Identity

Language

  • eng

PubMed Central ID

  • PMC4333639

Digital Object Identifier (DOI)

  • 10.1002/cncr.23658

PubMed ID

  • 18666210

Additional Document Info

start page

  • 1097

end page

  • 106

volume

  • 113

number

  • 5